RAD51 and breast cancer: Analysis of RAD51 G135C variant and BC clinicopathological features revealed that the heterozygous (G/C) genotype reduced BC risk in women with elevated BMI (overweight and obese) [OR: 0.57 (95% CI: 0.36–0.91); p = 0.017].